Exact Mass: 335.98195780000003
Exact Mass Matches: 335.98195780000003
Found 120 metabolites which its exact mass value is equals to given mass value 335.98195780000003
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. NBQX has neuroprotective and anticonvulsant activity[1].
beta-D-fructose 2,6-bisphosphate
C6H10O12P2 (335.96475200000003)
beta-d-fructose 2,6-bisphosphate is soluble (in water) and an extremely strong acidic compound (based on its pKa). beta-d-fructose 2,6-bisphosphate can be found in a number of food items such as chinese mustard, mexican oregano, chickpea, and saskatoon berry, which makes beta-d-fructose 2,6-bisphosphate a potential biomarker for the consumption of these food products.
[1S-[1a(Z),3a,4b]]-3-(3-Bromo-4-chloro-4-methylcyclohexyl)-4-oxo-2-pentenoic acid methyl ester
2-[4-(Bromomethyl)phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol
C10H7BrF6O (335.95844239999997)
ethyl 4-acetyloxy-7-bromonaphthalene-2-carboxylate
C15H13BrO4 (335.99971580000005)
Ethyl 4-acetoxy-6-bromo-2-naphthoate
C15H13BrO4 (335.99971580000005)
3-[2-Chloro-4-(5-nitrothiazol-2-ylazo)anilino]propiononitrile
2-(3-Methoxyphenylthio)-1-(4-bromophenyl)ethanone
C15H13BrO2S (335.98195780000003)
3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
4-BROMO-1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDINE
ALPHA-D-MANNOSE-1-PHOSPHATE DIPOTASSIUM SALT DIHYDRATE
sodium 1,1,3,3,3-pentafluoro-2-(pivaloyloxy)propane-1-sulfonate
1-Benzenesulfonyl-5-bromo-1H-pyrrolo[2,3-b]pyridine
disodium,[(2R)-2-[(1S)-1,2-dihydroxyethyl]-3-oxido-5-oxo-2H-furan-4-yl] sulfate
3-(3-Bromophenyl)-4-(4-chlorophenyl)butan-2-one
C16H14BrClO (335.99164840000003)
2-Bromo-N-(4-methoxybenzyl)-6-nitroaniline
C14H13BrN2O3 (336.01094880000005)
Nifurzide
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
METHYL 3-(N-(4-CHLORO-3-METHYLISOXAZOL-5-YL)SULFAMOYL)THIOPHENE-2-CARBOXYLATE
C10H9ClN2O5S2 (335.96414139999996)
2-Bromo-N-(4-methoxybenzyl)-4-nitroaniline
C14H13BrN2O3 (336.01094880000005)
3-Bromo-N-(4-methoxybenzyl)-2-nitroaniline
C14H13BrN2O3 (336.01094880000005)
2-Iodo-5-methyl-3-(5-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridine
2,6-BIS-(4-CHLORO-PHENYL)-TETRAHYDRO-THIOPYRAN-4-ONE
ethyl 6-bromo-8-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate
2-Bromo-4-methoxy-5-benzyloxybenzoic acid
C15H13BrO4 (335.99971580000005)
Benzo[b]thiophen-2-yl(5-bromo-2-fluorophenyl)methanol
SODIUM 2,2,3,3,4,4,5,5,6,6,6-UNDECAFLUOROHEXANOATE
2,4-DINITRO(HEPTAFLUOROISOPROPYL)BENZENE
C9H3F7N2O4 (335.99810420000006)
1-[(4-bromo-2-fluorophenyl)sulfonyl]-4-methylpiperazine
Recilisib
C16H13ClO4S (336.02230480000003)
Recilisib (ON 01210) is a radioprotectant, which can activate AKT, PI3K activities in cells[1].
Potassium bis(1,2-benzenediolato)(1,3-butadien-2-yl)silicate, min. 98
4-bromo-N-[(4-methoxyphenyl)methyl]-2-nitroaniline
C14H13BrN2O3 (336.01094880000005)
ethyl 6-broMo-2-(trifluoroMethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate
ethyl 5-broMo-2-(trifluoroMethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate
METHYL N-BOC-2-AMINO-5-BROMOTHIAZOLE-4-CARBOXYLATE
C10H13BrN2O4S (335.97793580000007)
1-(2-bromo-1,1,1,3,3,3-hexafluoropropan-2-yl)-2-methoxybenzene
C10H7BrF6O (335.95844239999997)
N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine
C14H7ClF2N4O2 (336.02255759999997)
3-chloro-5-phenylmethoxy-1-benzothiophene-2-carbonyl chloride
C16H10Cl2O2S (335.97785400000004)
Galactose 1-phosphate Potassium salt
Galactose 1-phosphate Potassium salt is is an intermediate in the galactose metabolism and nucleotide sugars.
3,6-dichloro-N-(4-methyl-2-pyridinyl)-1-benzothiophene-2-carboxamide
C15H10Cl2N2OS (335.98908700000004)
(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-methylsulfonylprop-2-enenitrile
2-(2,4-Dichlorophenyl)-5-[2-(methylthio)phenyl]-1,3,4-oxadiazole
C15H10Cl2N2OS (335.98908700000004)
beta-D-fructose 2,6-bisphosphate
C6H10O12P2 (335.96475200000003)
beta-d-fructose 2,6-bisphosphate is soluble (in water) and an extremely strong acidic compound (based on its pKa). beta-d-fructose 2,6-bisphosphate can be found in a number of food items such as chinese mustard, mexican oregano, chickpea, and saskatoon berry, which makes beta-d-fructose 2,6-bisphosphate a potential biomarker for the consumption of these food products. β-d-fructose 2,6-bisphosphate is soluble (in water) and an extremely strong acidic compound (based on its pKa). β-d-fructose 2,6-bisphosphate can be found in a number of food items such as chinese mustard, mexican oregano, chickpea, and saskatoon berry, which makes β-d-fructose 2,6-bisphosphate a potential biomarker for the consumption of these food products.
[3,4-Dihydroxy-2-(hydroxymethyl)-5-(phosphonatooxymethyl)oxolan-2-yl] phosphate
C6H10O12P2-4 (335.96475200000003)
5-amino-1-(5-phosphonato-D-ribosyl)imidazole-4-carboxylate
C9H11N3O9P-3 (336.02329060000005)
beta-D-fructofuranose 1,6-bisphosphate(4-)
C6H10O12P2-4 (335.96475200000003)
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D007155 - Immunologic Factors D020011 - Protective Agents
D-tagatofuranose 1,6-bisphosphate(4-)
C6H10O12P2-4 (335.96475200000003)
alpha-D-glucose 1,6-bisphosphate(4-)
C6H10O12P2-4 (335.96475200000003)
beta-D-Fructose 2,6-bisphosphate
C6H10O12P2-4 (335.96475200000003)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1D-myo-inositol 3,4-biphosphate(4-)
C6H10O12P2-4 (335.96475200000003)
5-carboxylatoamino-1-(5-O-phosphonato-D-ribosyl)imidazole(3-)
C9H11N3O9P-3 (336.02329060000005)
1D-myo-inositol (2,4) bisphosphate
C6H10O12P2-4 (335.96475200000003)
D-myo-inositol (4,5)-bisphosphate
C6H10O12P2-4 (335.96475200000003)
3,6-dichloro-N-(3-pyridinylmethyl)-1-benzothiophene-2-carboxamide
C15H10Cl2N2OS (335.98908700000004)
D-fructofuranose 1,6-bisphosphate(4-)
C6H10O12P2-4 (335.96475200000003)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-[(2-Chlorophenyl)methylthio]-6-nitro-1,3-benzothiazole
2-Methyl-1-cyclopropanecarboxylic acid (7-bromo-4-oxo-2-pyrido[1,2-a]pyrimidinyl)methyl ester
C14H13BrN2O3 (336.01094880000005)
5-bromo-N-[(2-pyridinylamino)-sulfanylidenemethyl]-3-pyridinecarboxamide
1D-myo-inositol 3,5-bisphosphate(4-)
C6H10O12P2-4 (335.96475200000003)
alpha-D-fructofuranose 1,6-bisphosphate(4-)
C6H10O12P2-4 (335.96475200000003)
[(2S,3R,4S,5R,6R)-2,3,5-trihydroxy-6-(phosphonatooxymethyl)oxan-4-yl] phosphate
C6H10O12P2-4 (335.96475200000003)
5-amino-1-(5-phosphonato-D-ribosyl)imidazole-4-carboxylate
C9H11N3O9P (336.02329060000005)
Trianion of 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid.
beta-D-fructofuranose 1,6-bisphosphate(4-)
C6H10O12P2 (335.96475200000003)
A D-fructofuranose 1,6-bisphosphate(4-) that is the conjugate base of beta-D-fructofuranose 1,6-bisphosphate.
alpha-D-glucose 1,6-bisphosphate(4-)
C6H10O12P2 (335.96475200000003)
A quadruply-charged organophosphate oxoanion arising from deprotonation of the phosphate OH groups of alpha-D-glucose 1,6-bisphosphate; major species at pH 7.3.
beta-D-fructofuranose 2,6-bisphosphate(4-)
C6H10O12P2 (335.96475200000003)
An organophosphate oxoanion that is the tetraanion of beta-D-fructofuranose 2,6-bisphosphate.
5-carboxylatoamino-1-(5-O-phosphonato-D-ribosyl)imidazole(3-)
C9H11N3O9P (336.02329060000005)
Trianion of 5-carboxyamino-1-(5-phospho-D-ribosyl)imidazole arising from deprotonation of phosphate and carbamic acid functions.
nbqx
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. NBQX has neuroprotective and anticonvulsant activity[1].
D-fructofuranose 1,6-bisphosphate(4-)
C6H10O12P2 (335.96475200000003)
An organophosphate oxoanion obtained by removal of all four protons from the phosphate OH groups of D-fructofuranose 1,6-bisphosphate.
alpha-D-fructofuranose 1,6-bisphosphate(4-)
C6H10O12P2 (335.96475200000003)
A D-fructofuranose 1,6-bisphosphate(4-) that is the conjugate base of alpha-D-fructofuranose 1,6-bisphosphate.
D-tagatofuranose 1,6-bisphosphate(4-)
C6H10O12P2 (335.96475200000003)
A organophosphate oxoanion that is the tetraanion of D-tagatofuranose 1,6-bisphosphate.
1D-myo-inositol 1,4-bisphosphate(4-)
C6H10O12P2 (335.96475200000003)
An organophosphate oxoanion arising from deprotonation of the phosphate OH groups of 1D-myo-inositol 1,4-bisphosphate; major species at pH 7.3.
1D-myo-inositol 3,4-biphosphate(4-)
C6H10O12P2 (335.96475200000003)
An inositol phosphate oxoanion obtained by deprotonation of the phospho groups of 1D-myo-inositol 3,4-biphosphate; major species at pH 7.3.
1D-myo-inositol 1,3-biphosphate(4-)
C6H10O12P2 (335.96475200000003)
An inositol phosphate oxoanion obtained by deprotonation of the phospho groups of 1D-myo-inositol 1,3-biphosphate; major species at pH 7.3.